Zimmer Biomet
ZBH · NYSE · USD · Healthcare
1What is happening
Zimmer Biomet has fallen 6% since its 6-week high on 04/11/2026. How it continues – phase and signs – you see with a free account.
Free account · 3 stocks and coins a dayfrom the 6-week high-6.2%
Other view · 21 analystsHorizon: 12 months7 Buy · 20 Hold · 0 Sell2Our assessment
No dip44How it continues – phase and signs – you see with a free account.
3Your next step
Marking places no order – it only helps you keep track.
More details · reasons, figures, alerts
How deep is the dip?
- from the 6-week high-6.2%
Highest daily price: $112.55 on 04/11/2026 · reference of the assessment · also the highest of the last 3 months
- from the 52-week high-6.2%
Highest price in 52 weeks: $112.55 (Yahoo)
What analysts expect
21 analysts disagree. They look about 12 months ahead – DipCatcher only 14 trading days.
- Buy
- 726 %
- Hold
- 2074 %
- Sell
- 00 %
Average price target$115.62
$97.00 to $130.00 · today $105.59
$97.00Ø $115.62$130.00
What is a price target?
The price an analyst expects in about 12 months. Estimates are often far apart and change frequently.
Third-party opinion, not an assessment by DipCatcher. Source: public analyst estimates, as of 08/11/2026. Not financial advice.
The company in figures
- Market value
- 20 bn $
- All shares together at the current price.
- P/E
- 26.7
- Price divided by earnings per share, last 12 months.
- Dividend yield
- 0.91 %
- Yearly dividend relative to the price.
- 52-week range
- $79.12 – $112.55
- Lowest and highest price of the last year.
Catalysts
36 h ago- News, last 10 days
- no recent news
- Next earnings
- —
- Last report
- 04/11/2026 +1.0% vs estimate
Key figures
- Market value
- 20.0 bn $Large cap
- P/E
- 26.7
- Dividend yield
- 0.91 %
- Volume today
- 1.3 × Øabout usual
- Beta
- 0.47swings less than the market
- 52-week range
- $79.12 – $112.55price at 79 % of the range
About Zimmer Biomet
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
- Headquarters:
- Warsaw, United States
- 52-week range:
- $79.12 – $112.55
- Website:
- zimmerbiomet.com
Trade levels
Why the engine says so
History for this stock or coin
Watch and alert
See which stocks they are
The engine is watching these dips right now. A free account shows the names and opens 3 full analyses a day.
- 3 full analyses a dayWith entry, target, stop and the reasons behind them.
- WatchlistFollow the stocks you care about.
Free, no payment details.
Signals are generated automatically from price, volume and technical indicators. They are not investment advice.← Back to search
Not investment advice. Investing carries risk up to total loss.
